The GCC Innovative Drug Discovery and Development (IDDD) Consortium would like to invite you to register to audit our 5th Annual Foundations of Cancer Therapeutics Course that will take place from 10 am – 4 pm, August 11-15.  This year’s 1-week course will focus on therapeutic development from early discovery through clinical trials.  Note that while cancer therapeutics will be highlighted, the majority of what we will cover is disease-agnostic, so all with research in drug development are invited to join.  You can view the agenda here.

Confirmed speakers include Zhiqiang An, Univ. of Texas Health Science Houston; Sarah Hein, March Biosciences; Yejin Kim, Univ. of Texas Health Science Houston; Wenshe Ray Liu, IBT; Barry Morgan, HitGen; Kyoji Tsuchikama, Univ. of Texas Health Science Houston; and Jin Wang,  Baylor College of Medicine.